初级气管癌的结果和预后见解:一个多中心的回顾性研究
Aleksandra Piórek1, Aleksandra Napieralska2,3, Paweł Teterycz4,5
1Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Translational lung cancer research
|October 24, 2025
概括
激进治疗显著改善了罕见的原发性气管瘤的存活率. 女性性别,良好的表现状态和没有节点参与是这些呼吸道癌症的关键积极预后因素.
科学领域:
- 在瘤学瘤学.
- 呼吸系统医学 呼吸系统医学
- 癌症研究 癌症研究
背景情况:
- 初级气管瘤很少见,占呼吸道癌症的不到0.1%.
- 它们的稀有性和异质性带来了诊断和治疗方面的挑战.
- 这项研究评估了气管瘤的结果和预后因素.
研究的目的:
- 为了评估初级气管瘤的治疗结果.
- 为了确定影响生存的预后因素.
- 将当前的做法与历史数据进行比较.
主要方法:
- 在2017-2022年期间接受治疗的31名患者的回顾性分析.
- 收集的数据包括人口统计,病理和治疗细节.
- 使用卡普兰-梅尔和考克斯模型分析的整体存活率 (OS).
主要成果:
- 状细胞癌 (51.7%) 和腺囊性癌 (29.0%) 是最常见的.
- 激进治疗产生了明显更好的5年生存率 (35.7%),而不是息治疗 (0%).
- 有利的预后因素包括女性性别,良好表现状态 (WHO 0-1),以及缺少节点参与 (N0).
结论:
- 女性性别,良好表现状态和N0状态是有利的预后指标.
- 激进治疗显著改善了原发性气管瘤的结果.
- 多学科管理和早期诊断对于罕见的气管恶性瘤至关重要.
更多相关视频
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
932
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
相关概念视频
Trachea
4.7K
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
4.7K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
